UNIVERSITÀ DEGLI STUDI DI VERONA Patent applications |
Patent application number | Title | Published |
20130196315 | DEVICE FOR CELL CULTURE AND ANALYSIS - The present invention relates to a device for cell culture and analysis, comprising a first containing element, a second containing element sealingly couplable to one another to define a culture chamber and a flexible film housable in said culture chamber and available alternatively on one of said first element or second element. The flexible film can be made of a transparent material selected from the group consisting of polycarbonate, polystyrene and polyethylene. A method for cell analysis is also provided. | 08-01-2013 |
20120034168 | Isolated Monoclonal Antibody or Fragment Thereof Binding Prostate Specific Membrane Antigen, Conjugates and Uses Thereof - An isolated monoclonal antibody or fragment thereof binding prostate specific membrane antigen (PSMA) preferably in its native form on the surface of tumour cells. A conjugate of the antibody with an active ingredient and modified forms of the antigen-binding antibody fragment are also provided. The complete antibody and the antigen-recognising fragment thereof are used alone or conjugated for the treatment and the diagnosis of tumours or tissues associated to the tumour overexpressing the PSMA antigen, preferably prostatic neoplastic diseases. | 02-09-2012 |
20110289630 | METHOD FOR THE EXPRESSION IN PLANT OF THE GLUTAMIC ACID DECARBOXYLASE (GAD65) AND RELATED EXPRESSION VECTORS - The present invention concerns a method of expression in plant of glutamic acid decarboxylase (GAD65), particularly a mutated form of human GAD65 (GAD65mut), and expression vectors thereof. | 11-24-2011 |
20100196919 | PEPTIDES, ANTIBODIES AND FRAGMENTS THEREOF FOR THE TREATMENT AND DIAGNOSTIC OF CELIAC DISEASE - The present invention discloses a peptide having an amino acid sequence comprising an epitope recognized by Igs of patients with active celiac disease and not recognized by Igs of patients on gluten-free diet, antibodies directed against this peptide and methods for diagnosing the celiac disease in a subject, or to check the effect of a therapy or of a diet treatment in a celiac disease affected subject, or to assess the risk of developing celiac disease in a subject vaccinated with a Rotavirus VP7 protein. | 08-05-2010 |